Abraham Ceesay

Chief Executive Officer at RAPP; Director at PCRX; President at Cerevel Therapeutics Holdings, Inc.

Filed with the SEC as Ceesay Abraham

Sold, on record
$11.6M
Dollars the filings state
Form 4 sales
20
Latest Oct 21, 2026
Form 144 notices
11
Proposed sales
Quarters with a sale
6 of the last 8
16 days with a sale in that time
Companies
3
Filed as an executive or holder

Companies

Sales by reason

15
Routine
0
Plan not stated
0
No plan
5
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. Oct 21, 2026Routine

    RAPP

    Sold 0.5% of their holdings

    $64k2,210 shares at $29.16

    Filed Oct 23, 2026Form 4

  2. Oct 7, 2026Routine

    RAPP

    Sold 1% of their holdings

    $143k4,522 shares at $31.68

    Filed Oct 8, 2026Form 4

  3. Oct 6, 2026Notice

    RAPP

    Filed a notice to sell 39,470 shares

    $1.2M39,470 shares

    Filed Oct 6, 2026Form 144

  4. Sep 23, 2026Routine

    RAPP

    Sold 0.5% of their holdings

    $87k2,210 shares at $39.17

    Filed Sep 24, 2026Form 4

  5. Sep 8, 2026Routine

    RAPP

    Sold 1.8% of their holdings

    $375k8,210 shares at $45.62

    Filed Sep 9, 2026Form 4

  6. Aug 25, 2026Routine

    RAPP

    Sold 3.9% of their holdings

    $938k18,921 shares at $49.57

    Filed Aug 26, 2026Form 4

  7. Aug 11, 2026Unusual

    RAPP

    Sold 9.6% of their holdings

    $2.4M51,499 shares at $47.24

    Filed Aug 12, 2026Form 4

  8. Jul 27, 2026Routine

    RAPP

    Sold 0.4% of their holdings

    $93k2,210 shares at $42.11

    Filed Jul 29, 2026Form 4

  9. Jul 14, 2026Routine

    RAPP

    Sold 1.5% of their holdings

    $328k8,210 shares at $40.00

    Filed Jul 15, 2026Form 4

  10. Jun 29, 2026Routine

    RAPP

    Sold 1.5% of their holdings

    $327k8,220 shares at $39.83

    Filed Jul 1, 2026Form 4

10 of 31

Every transaction

Every transaction on a Form 4 or Form 5 by Abraham Ceesay
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Oct 21, 2026Oct 23, 2026RAPPChief Executive OfficerSold2,210$29.16$64k450,035SEC
Oct 7, 2026Oct 8, 2026RAPPChief Executive OfficerSold4,522$31.68$143k452,245SEC
Sep 23, 2026Sep 24, 2026RAPPChief Executive OfficerSold2,210$39.17$87k456,767SEC
Sep 8, 2026Sep 9, 2026RAPPChief Executive OfficerSold8,210$45.62$375k458,977SEC
Aug 25, 2026Aug 26, 2026RAPPChief Executive OfficerSold18,921$49.57$938k467,187SEC
Aug 11, 2026Aug 12, 2026RAPPChief Executive OfficerSold51,499$47.24$2.4M486,108SEC
Jul 27, 2026Jul 29, 2026RAPPChief Executive OfficerSold2,210$42.11$93k537,607SEC
Jul 14, 2026Jul 15, 2026RAPPChief Executive OfficerSold8,210$40.00$328k539,817SEC
Jun 29, 2026Jul 1, 2026RAPPChief Executive OfficerSold8,220$39.83$327k548,027SEC
May 8, 2026May 11, 2026CRLDirectorAwarded1,438$177.62$255k2,384SEC
Feb 18, 2026Feb 19, 2026RAPPChief Executive OfficerSold10,916$29.35$320k20,729SEC
Feb 2, 2026Feb 4, 2026RAPPChief Executive OfficerAwardedStock Option (Right to Buy)428,000428,000SEC
Jan 20, 2026Jan 22, 2026RAPPChief Executive OfficerSold10,916$26.12$285k25,812SEC
Dec 17, 2025Dec 18, 2025RAPPChief Executive OfficerSold10,916$29.64$324k30,895SEC
Nov 17, 2025Nov 18, 2025RAPPChief Executive OfficerSold10,916$25.20$275k35,978SEC
Oct 15, 2025Oct 16, 2025RAPPChief Executive OfficerSold10,916$25.81$282k41,061SEC
Sep 17, 2025Sep 19, 2025RAPPChief Executive OfficerSold76,420$26.32$2M46,144SEC
Sep 4, 2025Sep 8, 2025PCRXDirectorSold2,354$27.19$64k9,039SEC
Jun 11, 2025Jun 13, 2025PCRXDirectorAwardedStock Option (Right to Buy)11,27911,279SEC
Jun 11, 2025Jun 13, 2025PCRXDirectorAwarded6,16311,393SEC
Jun 2, 2025Jun 4, 2025CRLDirectorAwardedStock Options (Right to Buy)2,082$135.04$281k2,082SEC
Jun 2, 2025Jun 4, 2025CRLDirectorAwarded946$135.04$128k946SEC
Feb 3, 2025Feb 4, 2025RAPPChief Executive OfficerAwardedStock Option (Right to Buy)428,000428,000SEC
Jun 12, 2024Jun 13, 2024PCRXDirectorAwardedStock Option (Right to Buy)12,17912,179SEC
Jun 12, 2024Jun 13, 2024PCRXDirectorAwarded5,2305,230SEC
Jun 6, 2024Jun 10, 2024RAPPChief Executive OfficerAwardedStock Option (Right to Buy)530,647530,647SEC
Oct 6, 2023Oct 11, 2023PCRXDirectorAwardedStock Option (Right to Buy)30,96730,967SEC
Feb 6, 2023Feb 8, 2023Cerevel Therapeutics Holdings, Inc.PresidentAwardedStock Option (Right to Buy)143,52829,083SEC
Sep 8, 2022Sep 12, 2022Cerevel Therapeutics Holdings, Inc.PresidentSold19,210$32.50$624k0SEC
Sep 8, 2022Sep 12, 2022Cerevel Therapeutics Holdings, Inc.PresidentExercised or settledStock Option (Right to Buy)19,210365,009SEC
Sep 8, 2022Sep 12, 2022Cerevel Therapeutics Holdings, Inc.PresidentExercised options19,210$13.17$253k19,210SEC
Aug 22, 2022Aug 24, 2022Cerevel Therapeutics Holdings, Inc.PresidentSold9,605$32.50$312k0SEC
Aug 22, 2022Aug 24, 2022Cerevel Therapeutics Holdings, Inc.PresidentExercised or settledStock Option (Right to Buy)9,605384,219SEC
Aug 22, 2022Aug 24, 2022Cerevel Therapeutics Holdings, Inc.PresidentExercised options9,605$13.17$126k9,605SEC
Aug 15, 2022Aug 17, 2022Cerevel Therapeutics Holdings, Inc.PresidentSold9,606$34.12$328k0SEC
Aug 15, 2022Aug 17, 2022Cerevel Therapeutics Holdings, Inc.PresidentExercised or settledStock Option (Right to Buy)9,606393,824SEC
Aug 15, 2022Aug 17, 2022Cerevel Therapeutics Holdings, Inc.PresidentExercised options9,606$13.17$127k9,606SEC
Aug 8, 2022Aug 9, 2022Cerevel Therapeutics Holdings, Inc.PresidentSold57,635$34.54$2M0SEC
Aug 8, 2022Aug 9, 2022Cerevel Therapeutics Holdings, Inc.PresidentExercised or settledStock Option (Right to Buy)57,635403,430SEC
Aug 8, 2022Aug 9, 2022Cerevel Therapeutics Holdings, Inc.PresidentExercised options57,635$13.17$759k19,211SEC
Feb 9, 2022Feb 11, 2022Cerevel Therapeutics Holdings, Inc.PresidentAwardedStock Option (Right to Buy)120,310120,310SEC
Jun 1, 2021Jun 3, 2021Cerevel Therapeutics Holdings, Inc.PresidentAwardedStock Option (Right to Buy)461,065461,065SEC
Jan 17, 2018Jan 19, 2018scPharmaceuticals Inc.Chief Operating OfficerAwardedStock Option (Right to Buy)80,97180,971SEC

Sales and notices (31)

Form 144 notices and Form 4 sales by Abraham Ceesay
Source
Oct 21, 2026Oct 23, 2026RAPPChief Executive OfficerForm 4 sale2,210$64k0.5%RoutineSEC
Oct 7, 2026Oct 8, 2026RAPPChief Executive OfficerForm 4 sale4,522$143k1.0%RoutineSEC
Oct 6, 2026Oct 6, 2026RAPPChief Executive OfficerForm 144 notice39,470$1.2MNoticeSEC
Sep 23, 2026Sep 24, 2026RAPPChief Executive OfficerForm 4 sale2,210$87k0.5%RoutineSEC
Sep 8, 2026Sep 9, 2026RAPPChief Executive OfficerForm 4 sale8,210$375k1.8%RoutineSEC
Aug 25, 2026Aug 26, 2026RAPPChief Executive OfficerForm 4 sale18,921$938k3.9%RoutineSEC
Aug 11, 2026Aug 12, 2026RAPPChief Executive OfficerForm 4 sale51,499$2.4M9.6%UnusualSEC
Jul 27, 2026Jul 29, 2026RAPPChief Executive OfficerForm 4 sale2,210$93k0.4%RoutineSEC
Jul 14, 2026Jul 15, 2026RAPPChief Executive OfficerForm 4 sale8,210$328k1.5%RoutineSEC
Jun 29, 2026Jul 1, 2026RAPPChief Executive OfficerForm 4 sale8,220$327k1.5%RoutineSEC
Jun 29, 2026Jun 29, 2026RAPPChief Executive OfficerForm 144 notice99,480$4MNoticeSEC
Jun 12, 2026Jun 12, 2026PCRXDirectorForm 144 notice9,039$210kNoticeSEC
Feb 18, 2026Feb 19, 2026RAPPChief Executive OfficerForm 4 sale10,916$320k1.9%RoutineSEC
Jan 20, 2026Jan 22, 2026RAPPChief Executive OfficerForm 4 sale10,916$285k1.9%RoutineSEC
Dec 17, 2025Dec 18, 2025RAPPChief Executive OfficerForm 4 sale10,916$324k1.9%RoutineSEC
Dec 17, 2025Dec 17, 2025RAPPChief Executive OfficerForm 144 notice15,249$469kNoticeSEC
Dec 17, 2025Dec 17, 2025RAPPChief Executive OfficerForm 144 notice17,499$538kNoticeSEC
Nov 17, 2025Nov 18, 2025RAPPChief Executive OfficerForm 4 sale10,916$275k1.9%RoutineSEC
Oct 15, 2025Oct 16, 2025RAPPChief Executive OfficerForm 4 sale10,916$282k1.8%RoutineSEC
Sep 17, 2025Sep 19, 2025RAPPChief Executive OfficerForm 4 sale76,420$2M11.5%RoutineSEC
Sep 17, 2025Sep 17, 2025RAPPChief Executive OfficerForm 144 notice52,501$1.4MNoticeSEC
Sep 17, 2025Sep 17, 2025RAPPChief Executive OfficerForm 144 notice45,751$1.2MNoticeSEC
Sep 4, 2025Sep 8, 2025PCRXDirectorForm 4 sale2,354$64k20.7%RoutineSEC
Sep 4, 2025Sep 4, 2025PCRXDirectorForm 144 notice2,354$64kNoticeSEC
May 8, 2023May 8, 2023Cerevel Therapeutics Holdings, Inc.PresidentForm 144 notice35,219$1.1MNoticeSEC
May 5, 2023May 5, 2023Cerevel Therapeutics Holdings, Inc.PresidentForm 144 notice35,220$1.1MNoticeSEC
May 4, 2023May 4, 2023Cerevel Therapeutics Holdings, Inc.PresidentForm 144 notice35,220$1.1MNoticeSEC
Sep 8, 2022Sep 12, 2022Cerevel Therapeutics Holdings, Inc.PresidentForm 4 sale19,210$624k100.0%UnusualSEC
Aug 22, 2022Aug 24, 2022Cerevel Therapeutics Holdings, Inc.PresidentForm 4 sale9,605$312k100.0%UnusualSEC
Aug 15, 2022Aug 17, 2022Cerevel Therapeutics Holdings, Inc.PresidentForm 4 sale9,606$328k100.0%UnusualSEC
Aug 8, 2022Aug 9, 2022Cerevel Therapeutics Holdings, Inc.PresidentForm 4 sale57,635$2M100.0%UnusualSEC